advisorsecurities master

FLNAFilana Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
15450
Ticker
FLNA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2000-07-14
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
FLNA

Detail

Enriched 2026-08-14 20:47

Market cap
$45,085,759.34
Shares outstanding (class)
48,307,896
Shares outstanding (weighted)
48,307,896
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
20
Location
AUSTIN, TX
Description

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data